Research
Norvartis (USA/EU) - Lubricin, SAR-315
University of New South Wales (Australia) - Atorvastatin
Sylentis (Spain) - Tivanisiran
IACTA Pharma (USA) - IC265, DENKI
Proteris Biotech (USA) - Protearin™
Mimtogen (Canada) - Taverlimide
Neuroptika (USA) - NRO-1
Dompé (Italy) - TRPM8, Platform IL-8, rhNGF
Azura Ophthalmics (Australia/Israel) - MD-001, MD-002, BL-007
RegeneRx (USA) - RGN-259
Proteris Biotech (USA) - Protearin™
Mimtogen (Canada) - Taverlimide
Neuroptika (USA) - NRO-1
Dompé (Italy) - TRPM8, Platform IL-8, rhNGF
Azura Ophthalmics (Australia/Israel) - MD-001, MD-002, BL-007
RegeneRx (USA) - RGN-259
Tarsus (USA) - TP-03
Oyster Point (USA) - OC-01
Silk-Tech (USA) - SDP-4
Axalbion (Switzerland) - TRPM8
Parion Sciences (USA) - P-321
Kala Pharmaceuticals (USA) - Eyesuvis™
Aldeyra Therapeutics (USA) - Rexproxalap
Pharmaleads (France) - PL265
University of Illinois (USA) - DNase
Oculis (Iceland) - OCS-02
Redwood Pharma (Sweden) - RP-101
Aerie Pharmaceuticals (USA) - AVX-012, JAKi/IKKbi
Nicox (USA) - NCX-4251
OKYO Pharma (USA) - Chermerin
Xigen (Switzerland) - XG-102, XG-104
Palatin Technologies (USA) - PL9643
Aviara Pharmaceuticals (USA) - AVA3486
Ocunova (USA) - OCU-001
Oyster Point (USA) - OC-01
Silk-Tech (USA) - SDP-4
Axalbion (Switzerland) - TRPM8
Parion Sciences (USA) - P-321
Kala Pharmaceuticals (USA) - Eyesuvis™
Aldeyra Therapeutics (USA) - Rexproxalap
Pharmaleads (France) - PL265
University of Illinois (USA) - DNase
Oculis (Iceland) - OCS-02
Redwood Pharma (Sweden) - RP-101
Aerie Pharmaceuticals (USA) - AVX-012, JAKi/IKKbi
Nicox (USA) - NCX-4251
OKYO Pharma (USA) - Chermerin
Xigen (Switzerland) - XG-102, XG-104
Palatin Technologies (USA) - PL9643
Aviara Pharmaceuticals (USA) - AVA3486
Ocunova (USA) - OCU-001
SiteOne Therapeutics (USA) - ST Topical
Allegro Ophthalmics (USA) - ALG-1007
BRIM Biotechnology (South Korea) - BRM-421
Allysta (USA) - ALY-688
Inflamalps (Switzerland) - INF101
Akari Therapeutics - Coversin
Quorum Innovations (USA) - Qi-401
Bessor Pharma (USA) - TSG-06
AxeroVision (USA) - AXR-159, AXR-270
VivaVision (China) - VN001
Abbvie (USA) - AGN-242428, AGN-231868
Allegro Ophthalmics (USA) - ALG-1007
BRIM Biotechnology (South Korea) - BRM-421
Allysta (USA) - ALY-688
Inflamalps (Switzerland) - INF101
Akari Therapeutics - Coversin
Quorum Innovations (USA) - Qi-401
Bessor Pharma (USA) - TSG-06
AxeroVision (USA) - AXR-159, AXR-270
VivaVision (China) - VN001
Abbvie (USA) - AGN-242428, AGN-231868